Skip to main content
. 2017 May;17(2):104–108. doi: 10.17305/bjbms.2017.1750

FIGURE 3.

FIGURE 3

Immunostaining for Ki-67 antigen in pituitary adenoma samples. (A) Null cell adenoma (0% Ki-67 expression); (B) Prolactin (PRL)-secreting adenoma with 4.3% of Ki-67 expression; (C) PRL-secreting adenoma with 4.5% expression of Ki-67; (D) PRL-secreting adenoma with 6.6% expression of Ki-67.